You searched for "lesions"
The ear, nose and throat anaesthesia practice of Dr John Snow (1813-58)
News of the first successful public demonstration of general anaesthesia in Boston, Massachusetts in October 1846 reached Britain in mid-December of that year. James Robinson, a London dentist, gave the first anaesthetic in the United Kingdom when, on 19 December,...The role of artificial intelligence and applications in ENT surgery
AI is progressing apace. If you’re wondering how it might affect our working lives in ENT, read on for insights and a pilot study that show us what may be possible. The recent launch of ChatGPT, an open access artificial...Interacoustics: Trends in Balance
I recently attended the 4th Annual Trends in Balance online course. Day one was optimizing the vestibular diagnostic test battery, day two looked at the functional balance assessments available and day three looked at vestibular rehabilitation.The British Acoustic Neuroma Association (BANA) Annual Conference 2025
The British Acoustic Neuroma Association (BANA) will host their Annual Conference this year in Ashover in the Peak District, this year focusing on members’ personal experiences. BANA (British Acoustic Neuroma Association) is a registered charity providing invaluable information and support to people with Acoustic Neuroma / Vestibular Schwannoma (ANVS) and their support networks.
Voice after posterior cordotomy: we think voice is bad, patients think it’s better!
Bilateral vocal fold immobility (BVFI) is a condition that can affect voice with an impact on quality of life (QOL). Surgical trauma from damage to bilateral recurrent laryngeal nerves, such as from previous thyroid, parathyroid, or mediastinal surgery are common...
Outcomes of larger glottic cancer volumes treated with radiotherapy
T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...
